Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinial Trials

Bristol-Myers Squibb (BMS) building

BMS buys Alzheimer’s player iPierian in $725m deal

Takes control of several promising candidates for neurodegenerative diseases

Biomarin

EC approves Biomarin rare genetic disorder drug

Vimizim now available to treat Morquio A syndrome

- PMLiVE

CTI launches cancer drug Pixuvri in UK

Now available to treat form of non-Hodgkin lymphoma

Chugai appoints US CMO

Athos Gianella-Borradori has clinical experience at Novartis and Merck Serono

- PMLiVE

Schmittgall wins Omega contract

German agency will lead promotion of several key products

- PMLiVE

Following the biologic path

Biosimilar regulations in Canada, the US and Europe all have a degree of uncertainty

Pegasus Moves to Brighton

Top UK Healthcare Communications Consultancy Moves to Brighton

Inizio

Sanofi reception

Sanofi won’t take part in mega-deal trend

CEO says French firm will stick to bolt-on acquisitions

- PMLiVE

Forest Labs agrees $1.46bn deal to buy Furiex

Gains access to promising IBS drug eluxadoline

- PMLiVE

GSK’s COPD drug Incruse cleared in Europe

Medicine is GSK’s first long-acting muscarinic antagonist

EU flag

J&J wins EU approval for diabetes combo

Vokanamet combines Invokana and metformin

- PMLiVE

Lonza appoints pharma COO

Marc Funk replaces Stephan Kutzer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links